目的:探讨眼睑局部注射A型肉毒杆菌对于眼睑痉挛的效果。方法:收集2022年7月~2024年2月被我院确诊为特发性眼睑痉挛的患者资料,筛选出其中符合条件者共78例作为研究对象。所有受试者均给予眼睑局部多点A型肉毒杆菌毒素治疗。本次研究中...目的:探讨眼睑局部注射A型肉毒杆菌对于眼睑痉挛的效果。方法:收集2022年7月~2024年2月被我院确诊为特发性眼睑痉挛的患者资料,筛选出其中符合条件者共78例作为研究对象。所有受试者均给予眼睑局部多点A型肉毒杆菌毒素治疗。本次研究中,选取的观察指标包括药疗效果、维持时间与不良反应。结果:A型肉毒杆菌毒素眼睑局部注射后,观察到痉挛症状大多1~7天完全缓解,有效治疗率约为98.7%。药物疗效大多可以维持3~6个月左右,并且并发症少。结论:A型肉毒杆菌毒素对于特发性眼睑痉挛患者进行眼睑局部注射治疗效果显著而且副作用少见,值得在临床上推广使用。Objective: To investigate the effect of local injection of Botulinum Toxin Type A into eyelid for blepharospasm. Methods: Data of patients diagnosed with idiopathic blepharospasm in our hospital from July 2022 to February 2024 were collected, and a total of 78 eligible patients were selected as research objects. All subjects were treated with local eyelid multipoint Botulinum Toxin Type A. In this study, the observational indicators included therapeutic effect, maintenance time and adverse reactions. Results: The symptoms of spasmodic were completely relieved in 1~7 days with an effective rate of 98.7%. The effect usually lasts for 3~6 mouths with few complications. Conclusion: Botulinum Toxin Type A given by local injection on multiple sites is more effective than acupuncture and moxibustion in the treatment of idiopathic ocular and facial spasmodic.展开更多
目的:探讨曲安奈德对核因子-κB(NF-κB)及血管内皮生长因子(VEGF)在大鼠视网膜新生血管病变中表达的影响。方法:选择7 d SD幼鼠40只,其中30只大鼠建立氧诱导的视网膜新生血管病变模型,10只置于正常环境中。30只大鼠中20只大鼠出氧箱后...目的:探讨曲安奈德对核因子-κB(NF-κB)及血管内皮生长因子(VEGF)在大鼠视网膜新生血管病变中表达的影响。方法:选择7 d SD幼鼠40只,其中30只大鼠建立氧诱导的视网膜新生血管病变模型,10只置于正常环境中。30只大鼠中20只大鼠出氧箱后给予玻璃体腔内注射曲安奈德1μl(0.04 mg),对侧眼注射平衡盐溶液(balanced saltsolution,BSS)作为对照,分为高氧+药物治疗组和高氧+BSS液对照组,每组20只眼;另10只大鼠作为高氧对照组。视网膜组织切片HE染色,免疫组织化学法检测NF-κB及VEGF的表达。结果:高氧+药物治疗组与高氧对照组及高氧+BSS组相比,新生血管内皮细胞核数目明显减少(P<0.01),高氧+药物治疗组的NF-κB及VEGF的表达均低于高氧对照组及高氧+BSS组(P<0.05)。VEGF表达升高的同时,NF-κB的表达呈升高趋势。结论:曲安奈德明显抑制NF-κB及VEGF的表达,即有抑制新生血管形成的作用,NF-κB与VEGF的表达呈正相关,在新生血管形成过程中起协同作用。展开更多
文摘目的:探讨眼睑局部注射A型肉毒杆菌对于眼睑痉挛的效果。方法:收集2022年7月~2024年2月被我院确诊为特发性眼睑痉挛的患者资料,筛选出其中符合条件者共78例作为研究对象。所有受试者均给予眼睑局部多点A型肉毒杆菌毒素治疗。本次研究中,选取的观察指标包括药疗效果、维持时间与不良反应。结果:A型肉毒杆菌毒素眼睑局部注射后,观察到痉挛症状大多1~7天完全缓解,有效治疗率约为98.7%。药物疗效大多可以维持3~6个月左右,并且并发症少。结论:A型肉毒杆菌毒素对于特发性眼睑痉挛患者进行眼睑局部注射治疗效果显著而且副作用少见,值得在临床上推广使用。Objective: To investigate the effect of local injection of Botulinum Toxin Type A into eyelid for blepharospasm. Methods: Data of patients diagnosed with idiopathic blepharospasm in our hospital from July 2022 to February 2024 were collected, and a total of 78 eligible patients were selected as research objects. All subjects were treated with local eyelid multipoint Botulinum Toxin Type A. In this study, the observational indicators included therapeutic effect, maintenance time and adverse reactions. Results: The symptoms of spasmodic were completely relieved in 1~7 days with an effective rate of 98.7%. The effect usually lasts for 3~6 mouths with few complications. Conclusion: Botulinum Toxin Type A given by local injection on multiple sites is more effective than acupuncture and moxibustion in the treatment of idiopathic ocular and facial spasmodic.
文摘目的:探讨曲安奈德对核因子-κB(NF-κB)及血管内皮生长因子(VEGF)在大鼠视网膜新生血管病变中表达的影响。方法:选择7 d SD幼鼠40只,其中30只大鼠建立氧诱导的视网膜新生血管病变模型,10只置于正常环境中。30只大鼠中20只大鼠出氧箱后给予玻璃体腔内注射曲安奈德1μl(0.04 mg),对侧眼注射平衡盐溶液(balanced saltsolution,BSS)作为对照,分为高氧+药物治疗组和高氧+BSS液对照组,每组20只眼;另10只大鼠作为高氧对照组。视网膜组织切片HE染色,免疫组织化学法检测NF-κB及VEGF的表达。结果:高氧+药物治疗组与高氧对照组及高氧+BSS组相比,新生血管内皮细胞核数目明显减少(P<0.01),高氧+药物治疗组的NF-κB及VEGF的表达均低于高氧对照组及高氧+BSS组(P<0.05)。VEGF表达升高的同时,NF-κB的表达呈升高趋势。结论:曲安奈德明显抑制NF-κB及VEGF的表达,即有抑制新生血管形成的作用,NF-κB与VEGF的表达呈正相关,在新生血管形成过程中起协同作用。